Speaking Engagements & Seminars Archive
 
Email Page
December 6, 2017
Ethics and Intellectual Property Traps, Pitfalls and Adventures in IP Lawyering
November 16, 2017
Strategic Approaches to Lexical Search
November 14, 2017
The Essentials of Depositions
November 10, 2017
Here and Now: Biosimilars for the treatment of IBD
November 1, 2017
Legal and IP Strategies to Strengthen Biosimilar Medicine Developers
October 30, 2017
Which Insurance Would Cover a Breach-Related Injury?
October 17, 2017
Cyber Security Laws & Trends in US
October 11, 2017
Cyber Risk and Liability Insurance: What Is It and Why You Need It
October 5, 2017
Chad Landmon Discusses Connecticut Science Center Sponsorship
October 4, 2017
Overview of Biological Products Law and Regulation
October 1, 2017
Rachel Adcox Presented a Guest Lecture to the Legal and Risk Management Institute in Tokyo
September 18, 2017
Aspen Skiing: Do You Have to Have Danced Before?
September 13, 2017
Biosimilars at the Bar: Legal Issues
August 30, 2017
Managing Your IP Spend: Containing Costs and Maintaining Quality
August 11, 2017
Actions to Recover Antitrust Damages
August 9, 2017
FDLI Webinar: Key Regulatory Issues in Biosimilars
July 19, 2017
Women Leaders in Life Sciences
June 14, 2017
Women in IP & Law
June 12, 2017
ACI's 8th Annual Summit on Biosimilars
June 12, 2017
Connecticut Legal Conference
June 6, 2017
GCR Live Antitrust Litigation USA
May 23, 2017
World Biosimilar Congress USA
May 11, 2017
Magna’s Mock Crisis; Part III
May 10, 2017
ACI Post Grant PTO Proceedings Conference
May 10, 2017
Operating Company vs Operating Company Litigation: A Proactive Defense
May 4, 2017
Key Regulatory Issues in Biosimilars
April 30, 2017
OffshoreAlert Conference
April 25, 2017
WEX Health Partner Conference
April 5, 2017
Emerging Trends in Antitrust Enforcement
March 30, 2017
Antitrust Thought Leaders Interview Series
March 29, 2017
Antitrust Enforcement in China
March 23, 2017
ACI 29th FDA Boot Camp
March 21, 2017
Securing Your First Law Firm Job
March 16, 2017
Trademark & Copyright Summit
March 3, 2017
Antitrust Practice Workshop: The Big Deal
March 1, 2017
Advanced Summit on Medical Device Patents
January 31, 2017
ACC Foundation Cybersecurity Summit
January 31, 2017
IP Practice in Japan
January 30, 2017
Intellectual Property Essentials for Entrepreneurs
January 24, 2017
Competition Counsel Day Conference
January 12, 2017
Judicial Clerkships: Why You May Want to Consider Applying for One
December 6, 2016
Webinar on FDA's New Final Rule Implementing the MMA and Amending ANDA and 505(b)(2) Practice
November 15, 2016
Axinn Attorneys Present at IP Strategy Summit
November 15, 2016
The Role of Factual Disputes in PTAB Institution Decisions in the Life Sciences
November 9, 2016
She Leads: Women in the Law
October 27, 2016
Aligning Your Enforcement Strategy with Business Goals
October 26, 2016
AIPLA’s IP Practice in Japan Pre-Meeting
October 20, 2016
FDLI: Biologics and Biosimilars
October 4, 2016
Rachel Adcox Presented Guest Lecture to Keiei Hoyu Kai in Tokyo
July 28, 2016
ACI Women Leaders in Life Sciences Law
June 16, 2016
New York State Bar Association, Why Antitrust?
June 13, 2016
ACI Summit on Biosimilars
June 8, 2016
John Harkrider Spoke at International Mergers & Acquisitions Conference
June 7, 2016
Rick Dagen Spoke at GCR's Antitrust Litigation USA Conference
June 2, 2016
Breaking Through "The Bamboo Ceiling"
May 23, 2016
ANDAs and 505(b)(2) Applications – Patent and Exclusivity Issues
May 10, 2016
KSR and 103: Tools You Can Use?
May 6, 2016
Ploy or Policy Tool - A Look at the Citizen Petition Process
April 10, 2016
Thomas Rohback Spoke at ACC Mid-Year Meeting
April 6, 2016
Rachel Adcox Moderated ABA Antitrust Spring Meeting Panel: Private Jury Trials: Reality or Reality TV?
March 17, 2016
Jonathan Harris Spoke Regarding Post Grant PTO Proceedings
March 16, 2016
The FTC's Section 5 Unfair Competition Guidelines Demystified
March 11, 2016
Chad Landmon Spoke on FDA's Citizen Petition Process
March 7, 2016
Axinn Attorneys Present Antitrust Update
February 29, 2016
Hot Topics and Issues in the Biosimilars Space
February 11, 2016
SCOTUS Update: Impact of Halo and Stryker on Enhanced Patent Damages Assessments
February 1, 2016
Maggie Spencer Spoke at NYSBA Annual Meeting
February 1, 2016
Suchira Ghosh Moderated Panel at NYSBA Annual Meeting
January 22, 2016
Rick Dagen Spoke before the Democratic Attorney General Association (DAGA) Regarding FTC State Action Guidance
December 15, 2015
Rachel Adcox Moderated ABA Competition Torts Committee Panel
November 6, 2015
The Role of In-House Counsel in Preparing for Trial (November 6, 2015)
October 20, 2015
ANDAs/505b2s & Patent and Exclusivity Issues
October 19, 2015
John Harkrider Spoke on IPR and Standardization Rules
October 8, 2015
New IP Financial Models: Innovation, Wall Street, and Patents
October 2015
Rick Dagen Spoke at a Department of Justice Training Session
September 28, 2015
Extraterritoriality of Antitrust Law in the US and Abroad: A Hot Issue
September 18, 2015
Cyber Security and Lawsuits – The Tip of the Iceberg (September 18, 2015)
September 10, 2015
Cybersecurity Litigation and the Role of Cyber Insurance (September 19, 2015)
September 8, 2015
GCR Live 3nd Annual New York Conference
September 2, 2015
Rick Dagen Spoke at the First Chair Awards
August 20, 2015
Daniel Bitton to Speak on China's Merger Reviews Under the Anti-Monopoly Law
July 23, 2015
Delphine Knight Brown Spoke at ACI’s Women Leaders in Life Sciences Law Conference
June 1, 2015
American Conference Institute's Sixth Annual Biosimilars Conference
June 1, 2015
George Mason University’s Annual Global Antitrust Economics Conference
May 29, 2015
FDLI: Introduction to Drug Law and Regulations, Biologics and Biosimilars
May 29, 2015
Rachel Adcox Spoke on Recent Developments in FTAIA Case Law
May 2015
Rick Dagen Spoke at a Federal Trade Commission Training Session
April 27, 2015
Delphine Knight-Brown Spoke At ACI Paragraph IV Disputes Conference
April 22, 2015
How to Break Your Adversary Without Breaking the Bank: IP Litigation Strategies
April 15, 2015
Rick Dagen Spoke at ABA Antitrust Law Spring Meeting
March 26, 2015
Jonathan Harris Spoke at The IP Strategy Summit
March 11, 2015
Chad Landmon Spoke at ACI's 24th FDA Boot Camp
February 25, 2015
HCT/P: FDA’s Newest Regulatory Battleground
February 4, 2015
Why Staples May Be Allowed to Buy Office Depot
December 3, 2014
Taking Stock of the State Action Doctrine In Light of North Carolina Board of Dental Examiners v. FTC
September 19, 2014
2014 Annual Competition Law Fall Conference
September 16, 2014
GCR Live 2nd Annual New York Conference
September 11, 2014
Conference on International Antitrust Law and Policy
September 9, 2014
A Single Merger Control Standard for the US and Abroad?
September 2014
Employment Contracts: What to Look For and How to Negotiate Them
August 2014
The Abbreviated NDA (ANDA), 505(b)(2) Applications and Patent and Exclusivity Issues
June 5, 2014
Demonstrating Biosimilarity: Guidance from the FDA
March 13, 2014
Marketing Exclusivities: Challenges, Opportunities and Current Controversies
January 27, 2014
The Abbreviated NDA (ANDA), 505(b)(2) Applications, and, Patent and Exclusivity Issues
January 9, 2014
Hot Topics in Generic Drug Entry and Regulation
June 28, 2013
Retrospective Analysis of Agency Determinations in Merger Transactions
June 27, 2013
Patent Hold-Up and Standard Essential Patents at the ITC
June 13, 2013
Chicago Forum on International Antitrust Issues
June 6, 2013
American Conference Institute's Biosimilars Conference
June 6, 2013
International Arbitration Roundtable
May 7, 2013
ACI's 7th Annual Paragraph IV Disputes Conference
May 1, 2013
FDLI's Introduction to Drug Law and Regulation
April 23, 2013
2013 FDLI Annual Conference
April 23, 2013
Trading in Secrets: Dealing with Employee and Data Mobility
March 27, 2013
Antitrust in the Obama Second Term: What to Expect
March 20, 2013
Bioequivalence - What Patent Lawyers Need to Know
March 5, 2013
Litigation and Prosecution Perspectives on The Obviousness of Medical Devices

View Current Speaking Engagements & Seminars ›